Galleros, Richelle Jane .
HRN: 27-80-66 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFUROXIME 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500mg
BID
S/P NSD With Repair; Thickly MSAF; UTI
Checking Initial Appropriateness
09/24/2025
METRONIDAZOLE 500MG (TAB)
09/24/2025
10/01/2025
ORAL
500mg
TID
S/P NSD With Repair; Thickly MSAF
Checking Initial Appropriateness
09/26/2025
METRONIDAZOLE 500MG (TAB)
09/26/2025
10/01/2025
PO
500mg
TID
THICKLY MSAF
Checking Initial Appropriateness
09/26/2025
CEFUROXIME 500MG (TAB)
09/26/2025
10/01/2025
PO
500mg
BID
UTI
Checking Initial Appropriateness